# MicroMatrix® Flex in Tunneling Wounds

> **NCT06629506** · NA · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 25 (actual)

## Conditions studied

- Pressure Injury
- Venous Ulcer
- Necrotizing Soft Tissue Infection
- Diabetic Ulcers
- Draining Wound

## Interventions

- **DEVICE:** MicroMatrix® Flex
- **DEVICE:** MicroMatrix® UBM Particulate
- **DEVICE:** Cytal® Wound Matrix 2-Layer

## Key facts

- **NCT ID:** NCT06629506
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-12
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629506, "MicroMatrix® Flex in Tunneling Wounds". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT06629506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*